Barry Kreiswirth, PhD, Chief Scientist & Co-Founder
Dr. Kreiswirth is a well-respected and foremost infectious disease expert who founded the Public Health Research
Institute's Tuberculosis Center. Dr. Kreiswirth is also an Adjunct Professor of Medicine at Columbia University
and an Adjunct Professor of Medicine at New York University (NYU). Dr. Kreiswirth previously held a position on
the DARPA Review Board, and is currently Vice President of the New York Academy of Sciences Microbiology
Advisory Board. In addition, Dr. Kreiswirth has served as an advisor to numerous pharmaceutical companies.
Dr. Kreiswirth has over 100 publications in respected journals such as "Nature", "Proceedings of the National
Academy of Science", "Journal of Infectious Disease", "Emerging Infectious Disease", and
"Journal of Molecular Biology". Dr. Kreiswirth recently wrote a book chapter on eGenomics DNA-based
fingerprinting methods for the CDC. Dr. Kreiswirth received a Ph.D. in Molecular Biology from NYU
Medical Center.
Sharon MacDonald, Director of Business Development
Ms. MacDonald is a seasoned Mergers and Acquisitions veteran having worked as an integration specialist
for several New York City-based financial firms. Ms. MacDonald co-founded The Oxer Group,a sister
company to Oxer Technologies with Mr. Naidich. Ms. MacDonald has a B.A. in Business Management from
Ithaca College and has studied at the London School of Economics.